Pharmaceutical development is the process of identifying and assessing the procedures required to turn an active pharmaceutical component into a drug product that is appropriate for the use for which it is intended. This will be for small-scale production of a product to be utilised in clinical trials in the early phases of medication development. In order to be appropriate for production on a commercial scale, the method will have to be modified and enhanced if the tests are successful. Measuring the characteristics of the drug material and determining the essential qualities of the desired medication product are the first steps in the pharmaceutical development process. This procedure will involve determining the drug's stability and absorption characteristics as well as the best route of delivery (oral, parenteral or for local administration). It is crucial to match the qualities of the drug material with the formulation required to achieve the clinical and commercial profile. Drug substance characteristics may significantly restrict the types of formulations that may be employed and necessitate in-depth research to fulfil the necessary profile. In order to create a successful commercial product, pharmaceutical development of the drug substance, the drug product, and its manufacturing behaviour are required if the drug application is successful. The finished product needs to be secure, dependable, and efficient.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada